August 2019 PMID 31185157

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Mansoor Husain, Andreas L Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G Eliaschewitz, Denise R Franco, Ole K Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D Pedersen, Cees J Tack, Mette Thomsen, Tina Vilsbøll, Mark L Warren, Stephen C Bain

Full text PDF Download social card

Mentions

234

Peak: 85 in Sep 2019

across 5 sources since Jun 2019

Extended reach

2,021,806

potential audience

Total likes

2,495

Video views

93,767

Mentions per month

Jun 2019 – Sep 2025

Where it's discussed

X / Twitter181 posts
News38 articles
Facebook8 posts
Blogs5 articles
YouTube2 videos

AI synopsis

What people are saying

The discussions demonstrate strong approval and interest, with mentions of trial results such as 'reduces cardiovascular events by 20%' and '2-year mortality benefits,' reflecting both enthusiasm and recognition of the study's importance. The tone varies from factual references to optimistic statements about the drug's potential, contributing to the overall moderate-to-high impact perception.

AgreementModerate agreement

Most discussions acknowledge the findings as supportive of oral semaglutide's cardiovascular safety and benefits, with many posts referencing trial results positively.

InterestHigh interest

The majority show high interest through mentions of mortality reduction, secondary endpoints, and implications for diabetes treatment.

EngagementModerate engagement

Posts often include specific data points, trial references, and comments on broader implications, indicating moderate deep engagement.

ImpactModerate impact

While some posts highlight significant findings, the overall tone suggests recognition of moderate to high impact, especially for clinical practice and future research.

Abstract in brief

Oral semaglutide was found to be safe for the heart in patients with type 2 diabetes at high cardiovascular risk, showing no increase in major adverse events compared to a placebo.
The study involved over 3,100 patients and lasted around 15 months, with results indicating that oral semaglutide reduced cardiovascular deaths and did not raise the risk of heart attacks or strokes.
Overall, the trial demonstrated that oral semaglutide is a noninferior treatment option regarding cardiovascular safety, supporting its use in managing type 2 diabetes with cardiovascular concerns.]

Read the full abstract

All mentions

Understanding GLP-1 Medications for Type 2 Diabetes

Ever wonder about medications like Trulicity, Ozempic, or Victoza? This video discusses the role of GLP-1 in managing blood glucose levels, how these medications function, their benefits, and potential side effects…

Sugar High · Apr 30, 2020 93,306 views

Impact of Ozempic on Eye Health Explained

Can Ozempic affect eye health? In this video, Dr. Abdul Rasheed discusses potential ocular effects associated with Ozempic, including risks of blurry vision and nonarteritic anterior ischemic optic neuropathy (NAION)…

Dr Abdul Rasheed · Sep 25, 2025 461 views

おだQ

@OdaQ_DM · X

PIONEER 6 Investigators. Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2019 Aug 29;381(9):841-851. doi: 10.1056/NEJMoa1901118. Epub 2019 Jun 11. PMID: 31185157. https://t.co/DcznGmn23E

May 8, 2025 · 3 likes · 15,252 followers View post →

NEJM Journal Watch

@JWatch · X

NEJM Group’s Dr. Lauren Westafer talks with Dr. Darren McGuire about his group’s trial on oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes who have increased cardiovascular risk. https://t.co/c5nEtE3bfG #ACC25 @LWestafer https://t.co/GsIavbfNYG

Mar 31, 2025 · 4 likes · 62,643 followers View post →

宇津貴史 /Utsu, Takashi

@Office_j · X

【補遺】 https://t.co/ecLZb9nDIW https://t.co/85rDihBS1O

Mar 14, 2025 · 4,919 followers View post →

shaffy

@shaffy8585 · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Nov 14, 2024 · 100 shares · 119 followers View post →

フロシンキ

@hurosinki · X

以前の試験(https://t.co/rxGudEnyYE)でMACEリスクの減少に有意差が付かなかったのをnを増やして確かめたかたち sglt2iの有無やBMIで効果が変わったりしないだろうか

Oct 26, 2024 · 1 like · 336 followers View post →

Mind Your Science!

@MindYourSci · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 22, 2024 · 22 shares · 132 followers View post →

Rx Readmore Livemore

@SopitaSirirata1 · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 22, 2024 · 22 shares · 175 followers View post →

Taha El-Ansary

@AT_El_Ansary · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 12,305 followers View post →

???

@wereturtle · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 116 followers View post →

Dr. Spencer Nadolsky

@DrNadolsky · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 59,394 followers View post →

Manuel Gaxiola

@cardiogax · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 7,993 followers View post →

Joe Gordon

@josephwgordon · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 2,111 followers View post →

Prof. Nasser Alzerwi

@NAlzerwi · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 1,741 followers View post →

Christopher Sylvain

@ChrisSylvain · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 592 followers View post →

Carlos del Rio

@CarlosdelRio7 · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 55,675 followers View post →

J M Antolinez-Motta

@DrAntolinez · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 1,051 followers View post →

| Daniel Sierra LM |

@DanielSierraLM · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 2,493 followers View post →

Ljiljana Lukic

@ljikson17 · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 132 followers View post →

ResearchPulse

@ResearchPulse1 · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 1,709 followers View post →

VictorHugoG.Johnson

@vikouerMD · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 814 followers View post →

Ankeet S. Bhatt, MD, MBA

@ankeetbhatt · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 2,894 followers View post →

Ranganath Muniyappa

@dr_muniyappa · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 1,097 followers View post →

Muthu Vaduganathan

@mvaduganathan · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 9,291 followers View post →

Juan Pablo Flores

@JuanPablo_Fs · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 172 followers View post →

Sivaprakasam Chinnarasu, PhD

@sivabdubio · X

RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…

Oct 21, 2024 · 22 shares · 101 followers View post →

Daniel J Drucker

@DanielJDrucker · X

Oct 21, 2024 · 68 likes · 22 shares · 34,676 followers View post →

Bebe

@justalilbebe · X

RT @mochihealth: #Semaglutide and Cardiovascular outcomes in T2DM: 3183 patients 50+ yo On Oral semaglutide vs placebo: ⬇️ 2 year mortal…

Oct 10, 2024 · 1 share · 159 followers View post →

VeeJayDont

@VeeJayDo2 · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 26, 2024 · 100 shares · 1,319 followers View post →

Riccardo M. Inciardi, MD, PhD

@RInciardi · X

RT @mvaduganathan: @arvindcanchi @hswapnil @RossNesbit @saugarmaripuri @brendonneuen Early CVOT #PIONEER6 n=3,183 pts w T2D+CV risk #MACE…

Jun 13, 2024 · 4 shares · 159 followers View post →

Brendon Neuen

@brendonneuen · X

RT @mvaduganathan: @arvindcanchi @hswapnil @RossNesbit @saugarmaripuri @brendonneuen Early CVOT #PIONEER6 n=3,183 pts w T2D+CV risk #MACE…

Jun 13, 2024 · 4 shares · 4,697 followers View post →

Graham Abra, MD

@GrahamAbra · X

RT @mvaduganathan: @arvindcanchi @hswapnil @RossNesbit @saugarmaripuri @brendonneuen Early CVOT #PIONEER6 n=3,183 pts w T2D+CV risk #MACE…

Jun 13, 2024 · 4 shares · 2,670 followers View post →

Arvind Canchi (Conjeevaram)

@arvindcanchi · X

RT @mvaduganathan: @arvindcanchi @hswapnil @RossNesbit @saugarmaripuri @brendonneuen Early CVOT #PIONEER6 n=3,183 pts w T2D+CV risk #MACE…

May 24, 2024 · 4 shares · 10,939 followers View post →

Muthu Vaduganathan

@mvaduganathan · X

@arvindcanchi @hswapnil @RossNesbit @saugarmaripuri @brendonneuen Early CVOT #PIONEER6 n=3,183 pts w T2D+CV risk #MACE PEP HR 0.79 95%CI 0.57-1.11 #ACM HR 0.51 95%CI 0.31-0.84 https://t.co/DdxDTC6RW3 Late CVOT #SOUL n=9,642 pts w T2D+CVD or CKD #MACE PEP Kidney composite & eGFR slope are secondary endpoints https://t.co/8nkIoFeAb4

May 24, 2024 · 5 likes · 4 shares · 9,291 followers View post →

Mind Your Science!

@MindYourSci · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 22, 2023 · 16 shares · 132 followers View post →

Dr Gail Ashford

@drgail3 · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 10, 2023 · 16 shares · 2,028 followers View post →

Kaushal Kashyap Ⓥ

@ktimesk · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 9, 2023 · 16 shares · 199 followers View post →

Uku Vainik

@ukuv · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 9, 2023 · 16 shares · 1,129 followers View post →

Jose C Souto, MD

@jcsouto · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 9, 2023 · 16 shares · 14,565 followers View post →

Aljosa Kuzmanovski

@Aljoo5 · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 9, 2023 · 16 shares · 108 followers View post →

Hugo Viegas

@HugoViegas_17 · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 9, 2023 · 16 shares · 18 followers View post →

Thomas Pinnock

@Thomas_Pinnock_ · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 9, 2023 · 16 shares · 182 followers View post →

Mary Lewis

@mem_lewis · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 8, 2023 · 16 shares · 1,441 followers View post →

Christian Tams MS RD LDN

@ChristianTams · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 8, 2023 · 16 shares · 1,254 followers View post →

Chase Campbell

@ChaseCa33292073 · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 8, 2023 · 16 shares · 85 followers View post →

Brock Golfs

@BrockGolfs · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 8, 2023 · 16 shares · 129 followers View post →

Aaron Lepeska

@AaronLepeska · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 8, 2023 · 16 shares · 189 followers View post →

Pere Joan Sala

@Fradbius · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 8, 2023 · 16 shares · 251 followers View post →

Kurt Harris MD

@radfugee · X

RT @sguyenet: Novo Nordisk reports that semaglutide 2.4 mg reduced cardiovascular events by 20% in ppl with obesity in the SELECT trial. C…

Aug 8, 2023 · 16 shares · 1,789 followers View post →

Stephan J. Guyenet

@sguyenet · X

Aug 8, 2023 · 49 likes · 16 shares · 49,008 followers View post →

Stephan J. Guyenet

@sguyenet · X

@DrRyanPDaly @MichaelAlbertMD There's already evidence that semaglutide reduces cardiovascular events comparably to statins in people with T2DM. https://t.co/oTQfAhNe79 https://t.co/dLsjoqY7Ns

Aug 2, 2023 · 8 likes · 49,008 followers View post →

Mochi Health

@mochihealth · X

#Semaglutide and Cardiovascular outcomes in T2DM: 3183 patients 50+ yo On Oral semaglutide vs placebo: ⬇️ 2 year mortality from cardiovascular causes ⬇️ 2 year mortality from any cause ↔️ no change in nonfatal MI/stroke,/heart failure PIONEER 6: https://t.co/LFrDu11SS0

Apr 14, 2023 · 3 likes · 1 share · 390 followers View post →

Dr.U@糖尿病メモ

@dr_ukio · X

PIONEER 6でCVDイベント安全性は評価済み。心血管病MACE)ハザード0.79 (0.57-1.11)なので、人数3倍であれば有意な結果にはなりそう。 https://t.co/S5XJFfL8XV

Mar 24, 2023 · 7,382 followers View post →

Karla Díaz

@karlaagui10 · X

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Dia... https://t.co/O9R8xAQGXP via @YouTube

Nov 22, 2022 · 2 likes · 1 followers View post →

د.عبدالرحمن جوهرجي

@drjoharji1 · X

@RabihNassar9 بناء على نتائج دراسة بايونير ٦ https://t.co/pT7YjYcLoB لم يتفوق على البلايسبو في حماية القلب عكس الاوزمبيك في دراسة sustain 6

Sep 25, 2022 · 88,943 followers View post →

Juan Senior

@jsenior64 · X

https://t.co/z5QilUO9Hj

Aug 16, 2022 · 11,087 followers View post →

Juan Senior

@jsenior64 · X

https://t.co/z5QilUO9Hj

Aug 16, 2022 · 11,087 followers View post →

DJD

@DJD81553730 · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Aug 13, 2022 · 100 shares · 916 followers View post →

Max Lugavere

@maxlugavere · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Aug 13, 2022 · 100 shares · 90,969 followers View post →

William Montaña

@WilliamMontaa10 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Jun 28, 2022 · 49 shares · 13 followers View post →

Christopher Labos

@drlabos · X

@drditlove Unfortunately, less cardiovascular benefit. And most of the weight loss trials were with injectable semaglutide though. https://t.co/qADMwys2Iy

May 8, 2022 · 3,382 followers View post →

The Cardiometabolic Forum

@theCMforum · X

Husain M et al. Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. @NEJM 2019. View the summary here: https://t.co/JCHWGlF9IM

Feb 17, 2022 · 256 followers View post →

syed shaban

@SydShaban · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Dec 2, 2021 · 100 shares · 249 followers View post →

أ.د. وليد البكر

@DrWaleedalbaker · X

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM https://t.co/lXeazVTECi

Oct 2, 2021 · 1 like · 45,548 followers View post →

benito Camela

@carlosedu1819 · X

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Facebook:https://t.co/HMxlBrjB97 Youtube :https://t.co/SyUqiPCRv8

Feb 9, 2021 · 6 likes · 144 followers View post →

Dr Carlos Palacio - Diabetes

@PalacioDr · X

RT @jsenior64: https://t.co/z5QilUO9Hj

Jan 11, 2021 · 1 share · 92 followers View post →

Juan Senior

@jsenior64 · X

https://t.co/z5QilUO9Hj

Jan 11, 2021 · 1 like · 1 share · 11,087 followers View post →

ぴょん（病院薬剤師）@大学病院分院

@byoyaku2019 · X

心血管疾患または慢性腎臓病がある50歳以上の2型糖尿病患者に対し、経口セマグルチドを投与した場合、""プラセボ""に比較し、心血管リスクプロファイルは非劣勢であった。主な心血管イベント発生率 3.8% vs 4.8% (HR 0.79;95%CI 0.27-0.92) https://t.co/Xdvf2U8BAM

Sep 10, 2020 · 2 likes · 35 followers View post →

Physician's Weekly

@physicianswkly · X

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/GSD9U1Z0uq

Aug 18, 2020 · 6,342 followers View post →

Annyka

@Annyka73458918 · X

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes , LINK VIDEO: https://t.co/1O9ekwufqw

Jul 28, 2020 View post →

RunTheList

@runthelistpod · X

REFs (part 1): [1]https://t.co/13yFRkA2QY [2]https://t.co/V0GVgFxea7 [3]https://t.co/p8geXZRCom [4]https://t.co/nZ6i7FyWgQ [5]https://t.co/5Z9ivg5bvG [6]https://t.co/XPeJTx7IQM [7]https://t.co/lDh3skGs5z [8]https://t.co/bQUTnrQbSB [9]https://t.co/21rdH5qbEo

Jun 24, 2020 · 4 likes · 8,157 followers View post →

おだQ

@OdaQ_DM · X

Jun 16, 2020 · 15 likes · 1 share · 15,252 followers View post →

International J Obesity

@IntJObesity · X

In the future, it would great to see larger trials of GLP-1 agonists & memory. Also, it would be interesting if the oral agent in this class (semaglutide) also protects cognition & memory. A previous RCT showed 50% less mortality w/ semaglutide https://t.co/yd2NB9L12j (#6/6)

Jun 13, 2020 · 1 like · 4,346 followers View post →

Steph Witek

@StephWitek · X

@KOBPharmD @US_FDA @novonordisk PIONEER 6 is published which demonstrated non-inferiority compared to placebo (so safe, but no benefit in composite outcome). A 5-year outcome trial is recruiting now though. https://t.co/qh7Ij5sBZg

Jan 17, 2020 · 1 like · 870 followers View post →

Michael Fralick

@FralickMike · X

@drjjw most definitely, the trial's point-estimate was impressive...but those 95% CI did not oblige [https://t.co/M7C9PK3Enx].

Dec 10, 2019 · 4,000 followers View post →

GrupoCronosSEFH

@GRUPOCRONOSSEF1 · X

Para hoy jueves refrescamos este artículo del mes pasado de @NEJM Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Disponible en: https://t.co/g3CYDkWxeb

Nov 7, 2019 · 1 like · 3,336 followers View post →

Omid Hakami Hakami

@Omidhakami · X

RT @FarmaMadridAP: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes via @NEJM https://t.co/mjG7ikfb7r

Sep 25, 2019 · 3 shares · 506 followers View post →

Salvador Rivera

@salvarivera · X

RT @FarmaMadridAP: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes via @NEJM https://t.co/mjG7ikfb7r

Sep 25, 2019 · 3 shares · 216 followers View post →

Marcelo Mario Avellanal Leal

@parreshia · X

RT @FarmaMadridAP: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes via @NEJM https://t.co/mjG7ikfb7r

Sep 25, 2019 · 3 shares · 2,002 followers View post →

Farmacia Madrid AP

@FarmaMadridAP · X

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes via @NEJM https://t.co/mjG7ikfb7r

Sep 25, 2019 · 2 likes · 3 shares · 8,410 followers View post →

KristopherMaday PA-C

@PA_Maday · X

PIONEER 6 Trial Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/jLHVJMtbYb https://t.co/Zf65V5o7o8

Sep 23, 2019 · 2,453 followers View post →

Diabetesgeneeskunde

@DiabGeneeskunde · X

PIONEER 5 (https://t.co/FFA9TT55if), PIONEER 6 (https://t.co/30XAPhQtd4), PIONEER 7 (https://t.co/enLTsRTOef) en PIONEER 8 (https://t.co/YqJzuNBjne) (2 van 2)

Sep 17, 2019 · 1 like · 197 followers View post →

Anand. A Hardikar

@AnandHardikar · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 11, 2019 · 100 shares · 846 followers View post →

rodrigo zumbado

@zumbadoMD · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 10, 2019 · 100 shares · 198 followers View post →

Dr. Gilberto Pérez López MD PhD

@Endocrino_PED · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 7, 2019 · 49 shares · 4,825 followers View post →

Umar Shakur

@u_shakur · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 6, 2019 · 49 shares · 295 followers View post →

Salud juntos

@alfonso_casi · X

Semaglutida oral y resultados cardiovasculares en pacientes con diabetes tipo 2: en diabéticos tipo 2 con alto riesgo cardiovascular, la primera aparición de un evento cardiovascular no difiere del placebo-> su seguridad no es inferior al del placebo. https://t.co/cNz2tJNzJN

Sep 6, 2019 · 8,557 followers View post →

かわうそ@知るも知らぬも

@kawauso_srmsrnm · X

お疲れ様です。今日の勉強会のお題は、NEJMの原著論文より、経口のGLP-1アナログについて、でした。 https://t.co/jnsGFd5Grm

Sep 6, 2019 · 73 followers View post →

Teja naveen

@tejanaveenbolem · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 5, 2019 · 100 shares · 101 followers View post →

散歩ミカン

@sanpo_mikan · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 4, 2019 · 49 shares · 339 followers View post →

散歩ミカン

@sanpo_mikan · X

2型糖尿病患者における経口セマグルチドと心血管転帰 Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. M. Husain and Others. N Engl J Med 2019; 381:841-851. https://t.co/B8EiDYWyTd

Sep 4, 2019 · 2 likes · 339 followers View post →

RODRIGO LUNA

@RODRIGO32984659 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 4, 2019 · 49 shares · 18 followers View post →

orlando henne

@ohenne2 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 4, 2019 · 49 shares · 253 followers View post →

leo uzych

@LeoUzych · X

Oral #Semaglutide and #Cardiovascular Outcomes in Patients with Type 2 #Diabetes | #NEJM https://t.co/5EyJmwKrxu

Sep 4, 2019 · 222 followers View post →

Dr.Marco Antonio C

@drmarcocamacho · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 4, 2019 · 49 shares · 1,150 followers View post →

Antonio Manteca

@amango30 · X

RT @RevistaMFSamfyc: Semaglutida oral y resultados cardiovasculares en pacientes con diabetes tipo 2 https://t.co/48VmUhozWO PMID 31185157

Sep 4, 2019 · 1 share · 138 followers View post →

Sophie Duméry Vive l'école !

@SophDum · X

Sémaglutide oral : ça existe ? Oui. Pas inférieur au placebo. Des choux gras pour tout le monde ?

Sep 4, 2019 · 1,294 followers View post →

María Antequera

@mellitus_1 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 4, 2019 · 49 shares · 1,607 followers View post →

SaludHEALTHinfo

@SaludHEALTHinfo · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 4, 2019 · 49 shares · 8,832 followers View post →

María Ballesteros

@mdballesteros · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 4, 2019 · 49 shares · 4,806 followers View post →

Akif Acay

@akifacay · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 246 followers View post →

Leslie David, MD

@Sportslad · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 186 followers View post →

PublicHealthMaps

@PublicHealthMap · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 6,342 followers View post →

Marina

@Marina_nefro · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 949 followers View post →

Ana Piera #JuntosEsMasFacil

@ana_apiecar · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 2,574 followers View post →

Iván

@Dockat16 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 87 followers View post →

Stefania Arciello

@StefaniaArciell · X

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM https://t.co/bQuSFrPUy0

Sep 3, 2019 · 1,940 followers View post →

ligiamendes

@ligiamendes76 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 30 followers View post →

Manuel Beltrán

@ManoloBeltranR · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 579 followers View post →

Carlos

@cavicae22 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 77 followers View post →

Revista MFAndalucia

@RevistaMFSamfyc · X

Semaglutida oral y resultados cardiovasculares en pacientes con diabetes tipo 2 https://t.co/48VmUhozWO PMID 31185157

Sep 3, 2019 · 1 share · 722 followers View post →

Cristobal Morales

@CristobMorales · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 17,147 followers View post →

Manuel Ruelas

@ManuelRuelas21 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 423 followers View post →

Tu Endocrino

@TuendocrinoSEEN · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 5,795 followers View post →

( ノ´.ㅅ` )ノรางวัลที่ 1 มาแน่!!!

@lexokkaz2 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 76 followers View post →

J. Cena

@DrJCena · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 167 followers View post →

Medical Research Library of Brooklyn

@DMCLibraryBKLYN · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 329 followers View post →

Hanna Gaggin

@HannaGaggin · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 3, 2019 · 100 shares · 1,606 followers View post →

Smileyploi:D

@Jpolyploid1 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 6 followers View post →

Dr.Yasser Alwali

@DrYasserAlwali · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 447 followers View post →

Unya S

@UnyaS · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 186 followers View post →

João Presume

@JoaoPresume · X

Great news in the treatment of diabetes! This will surely be of great value in cardiology #cardiotwitter #cardiology #diabetes https://t.co/NTAluqfjkF

Sep 3, 2019 · 259 followers View post →

Yevgen Zolotarov

@zolotarov · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 3, 2019 · 100 shares · 48 followers View post →

Dr. Perez-Belmonte

@belmonte_dr · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 150 followers View post →

FAM

@alvmufa · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 383 followers View post →

Rafael Aguilella

@rafaelaguilella · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 149 followers View post →

Dr. Karoki

@Dr_karoki · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 190 followers View post →

APL

@AndreaPestanaL · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 1,769 followers View post →

Jose Ferreira Santos

@japfs · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 237 followers View post →

平社員

@T462759 · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 274 followers View post →

Don Epezilo

@seinanathema · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 449 followers View post →

horottoilvetro

@horottoilvetro · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 3,108 followers View post →

M Shafi Kuchay

@drshafikuchay · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 19,906 followers View post →

Pharmacy Updates

@NaplexReviewQs · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 375 followers View post →

Dr Jean Pierre Laroche #vacciné 6.0

@Echoraljpangio · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 2,716 followers View post →

Mafer

@Mafer_XHP · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 627 followers View post →

Pub Health Monitor

@monitor_PH · X

RT @NEJM: #VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.…

Sep 3, 2019 · 49 shares · 1,822 followers View post →

NEJM

@NEJM · X

#VisualAbstract: Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes https://t.co/FuAPUe1QVJ https://t.co/vfSvtmms4a

Sep 3, 2019 · 75 likes · 49 shares · 935,567 followers View post →

Michael Buratovich

@MichaelBuratovi · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 2, 2019 · 100 shares · 1,172 followers View post →

Mehroz Ehsan

@mehrozehsan · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 2, 2019 · 100 shares · 453 followers View post →

François Marchildon

@FMarchildon · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 2, 2019 · 100 shares · 155 followers View post →

SEFAP

@Sefap_FAP · X

(N Engl J Med) Semaglutida oral y resultados cardiovasculares en pacientes con diabetes tipo 2 https://t.co/bIAtsZe1mv

Sep 2, 2019 · 7,961 followers View post →

Vladimir Heiskanen

@ValtsuH · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 2, 2019 · 100 shares · 809 followers View post →

Santito

@SantitoBastardo · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 2, 2019 · 100 shares · 65 followers View post →

Stephen Heitner

@HeitnerStephen · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 2, 2019 · 100 shares · 601 followers View post →

Dylan

@sp6c3inv6d3r · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 2, 2019 · 100 shares · 326 followers View post →

Paul Knoepfler

@pknoepfler · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 2, 2019 · 100 shares · 20,537 followers View post →

Jan Vyjidak

@janvyjidak · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 2, 2019 · 100 shares · 4,144 followers View post →

Biotech-Catalyst

@BIOTECH888 · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 212 followers View post →

Julio Valencia

@jucevam · X

RT @ValleAlfonso:

Sep 1, 2019 · 9 shares · 109 followers View post →

Zahraddin Abdullahi

@Xahraddin_A · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 1,370 followers View post →

Matthew Theisen

@RealTheisen · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 32 followers View post →

Yanfei Zhang

@zhyanfei123 · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 60 followers View post →

Abhishek Kulkarni

@AbhiKulk82 · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 519 followers View post →

Román Freixa Pamias

@rfreixap · X

RT @ValleAlfonso:

Sep 1, 2019 · 9 shares · 1,017 followers View post →

JUSTADUDE

@mookiemanboi · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 891 followers View post →

Jan Ehses

@JanEhses · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 1,729 followers View post →

Tune H. Pers

@tunepers · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 1,367 followers View post →

Raymond Francis Sarmiento, M.D.

@rfrsarmiento · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 1,545 followers View post →

George Thampy

@GeorgeThampy · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 879 followers View post →

George Dawson

@dawso007 · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Sep 1, 2019 · 100 shares · 7,825 followers View post →

Florian Wünnemann

@flowuenne · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Aug 31, 2019 · 100 shares · 471 followers View post →

SY Investing

@syinvesting · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Aug 31, 2019 · 100 shares · 5,228 followers View post →

subbakrishna rao

@SubkrishnaRao · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Aug 31, 2019 · 100 shares · 1,372 followers View post →

Amitoj Singh

@amitojdr · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Aug 31, 2019 · 100 shares · 180 followers View post →

The Addled Mind

@theAddledMind · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Aug 31, 2019 · 100 shares · 216 followers View post →

Afshine Emrani MD FACC

@EmraniMd · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Aug 31, 2019 · 100 shares · 2,168 followers View post →

Pablo Arrona

@PabloArrNutSci · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Aug 31, 2019 · 100 shares · 248 followers View post →

K Wary

@KishoreWary · X

RT @skathire: An oral drug which: 1. leads to meaningful weight loss 2. lowers all-cause mortality ~50% 3. lowers CV mortality 4. lowers hg…

Aug 31, 2019 · 100 shares · 649 followers View post →

Mike

@michaelscally · X

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes An oral drug which: 1. Leads to meaningful weight loss 2. Lowers all-cause mortality ~50% 3. Lowers CV mortality 4. Lowers hgA1C BACKGROUND - Establishing... https://t.co/Ht5RTG0irN

Aug 31, 2019 · 894 followers View post →

Jmfr

@Jmfr1979 · X

RT @redGDPS: Publicado el #PIONEER6

Aug 31, 2019 · 5 shares · 61 followers View post →

Enrique Carretero

@Enriq_Carretero · X

RT @redGDPS: Publicado el #PIONEER6

Aug 31, 2019 · 5 shares · 662 followers View post →

Belén Gonzalez Mohino #YoApoyoAPrimaria

@glez_mohino · X

RT @redGDPS: Publicado el #PIONEER6

Aug 30, 2019 · 5 shares · 120 followers View post →

Fernando Moya-Méndez E.

@DrMoyaMendezE · X

https://t.co/793rO0UfRj

Aug 30, 2019 · 120 followers View post →

Carlos Hdez Teixidó

@carlos_teixi · X

RT @redGDPS: Publicado el #PIONEER6

Aug 29, 2019 · 5 shares · 4,164 followers View post →

Fco Carramiñana Barrera

@fcbzafra · X

RT @redGDPS: Publicado el #PIONEER6

Aug 29, 2019 · 5 shares · 2,742 followers View post →

redGDPS Diabetes

@redGDPS · X

Publicado el #PIONEER6

Aug 29, 2019 · 8 likes · 5 shares · 15,561 followers View post →

Bibliosaude

@Bibliosaude · X

Oral Semaglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes https://t.co/1MOhNO3jQO

Jul 23, 2019 · 1 like · 1,878 followers View post →

Deutsches Zentrum für Diabetesforschung (DZD)

@DiabResearch · X

RT @PLID_Info: @Medizin_TUD @DiabResearch @NEJM Für alle Interessierten gibt es hier noch den Link zur Originalpublikation: https://t.co/bV…

Jun 22, 2019 · 1 share · 2,109 followers View post →

Paul Langerhans Institute Dresden - PLID

@PLID_Info · X

@Medizin_TUD @DiabResearch @NEJM Für alle Interessierten gibt es hier noch den Link zur Originalpublikation: https://t.co/bVa5dGtKBK

Jun 20, 2019 · 1 share · 815 followers View post →

Ted Kyle

@ConscienHealth · X

RT @ConscienHealth: Yet another #CVOT, this time in the @NEJM today, for #oral #semaglutide (#PIONEER6). Also presented at #ADA2019. https:…

Jun 12, 2019 · 1 share · 11,493 followers View post →

Ted Kyle

@ConscienHealth · X

Yet another #CVOT, this time in the @NEJM today, for #oral #semaglutide (#PIONEER6). Also presented at #ADA2019. https://t.co/y7F3Xex6jT

Jun 11, 2019 · 3 likes · 1 share · 11,493 followers View post →

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

Mentions per month

Where it's discussed

What people are saying

Abstract in brief

Top posts

All mentions

Understanding GLP-1 Medications for Type 2 Diabetes

Impact of Ozempic on Eye Health Explained